CD44 and cancer: A decade later, Al-Hajj’s team showed that as few as 100 cells with a CD44+CD24- phenotype could form tumors in mice, whereas tens of thousands of cells with alternate phenotypes failed to form tumors.4 Many other teams have also found that only a few fractions of cancer cells can reform secondary tumors after transplantation into immunodeficient mice.